Actual Medicinal Product (AMP) Valdoxan 25mg tablets (Servier Laboratories Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends store in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Valdoxan 25 mg film-coated tablets (Servier Laboratories Limited) and Agomelatine Zentiva 25mg film-coated tablets (Zentiva).

Generic
Agomelatine
Formulation
Agomelatine 25mg tablets
  • Agomelatine
    • Agomelatine 25mg tablets
      • Valdoxan 25mg tablets (Servier Laboratories Ltd)



Related Formulations (1)